HAPTEN-SPECIFIC TOLERANCE : PREFERENTIAL DEPRESSION OF THE HIGH AFFINITY ANTIBODY RESPONSE by Davie, Joseph M. et al.
HAPTEN-SPECIFIC  TOLERANCE 
PREFERENTIAL  DEPRESSION  OF  TIIE HIGH  AFFINITY  ANTIBODY  RESPONSE 
BY JOSEPH M. DAVIE, WILLIAM E. PAUL, DAVID H. KATZ, ANn BARUJ 
BENACERRAF 
(From  the  Laboratory of  Immunology,  National  Institute  of Allergy  and  Infectious 
Diseases, and  the  Laboratory of Pathology, National  Ca~cer Institute,  National 
Institutes of Health, Bethesda, Maryland  20014, and the Department of 
Pathology, Harvard Medical School, Boston, Massachusetts 02115) 
(Received for publication 26 April 1972) 
The  treatment  of guinea pigs with  2,4-dinitrophenyl  (DNP) t  derivatives  of the 
copolymer of D-glutamic acid and D-lysine (D-GL) induces a state of specific immuno- 
logic tolerance in the recipient (1). The type of tolerance induced is unusual in that it is 
DNP specific.  That is, challenge of such guinea pigs with a DNP conjugate of oval- 
bumin (DNP-OVA) elicits anti-DNP responses markedly smaller than those of animals 
which have  not been pretreated  with DNP-B-GL. The degree  of depression  in re- 
sponsiveness is related  to the dose of tolerogen,  to the mode of immunization with 
DNP-OVA, and  to the interval between the  two events.  A  similar  type of hapten- 
specific  tolerance, in mice, has recently been described by both Hraba et al.  (2)  and 
by Golan and Borel (3). 
The tolerant state, in this model, appears to be largely expressed in the precursors 
of antibody-secreting cells. The evidence for this view is the following: 
(a)  The number of DNP-specific antigen-binding lymphocytes in the lymph nodes 
of tolerized animals is markedly reduced (1).  These antigen-binding lymphocytes are 
members of the bone marrow-derived (B) lymphocyte pool and include the precursors 
of antibody-secreting cells (4). 
(b)  The tolerance is hapten specific  (1).  Thymus-derived (T)  lymphocytes acting 
as  "helpers"  in  the  activation  of precursor  cells  are  almost  exclusively  carrier  or 
conjugate specific  (5,  6); on the other hand,  hapten-specific precursors of antibody- 
secreting  cells  are relatively  common (4,  7).  Hapten-specific  tolerance  thus implies 
precursor cell tolerance. 
(c)  Even when an excess of helper cells are provided through an immunization with 
carrier  after  tolerance  induction with DNP-D-GL but before challenge with DNP- 
carrier  conjugate,  the  subsequent  anti-DNP  response  is  markedly  diminished  (1). 
Thus,  in  a  situation  in  which  helper  T  cells  are  not limiting,  the  hapten-specific 
tolerance is  easily demonstrable,  again implying a  defect in the population  of pre- 
cursors of antibody-secreting cells. 
1  Abbreviations used in  this paper: B  lymphocytes,  bone  marrow-derived  lymphocytes; 
DNP,  2,4-dinitrophenyl;  DNP-GPA,  dinitrophenylated  guinea  pig  albumin;  DNP-OVA, 
dinitrophenyl  conjugate  of ovalbumin;  D-GL, copolymer of D-glutamie acid  and  n-lysine; 
PFC,  plaque-forming  cells; T  lymphocytes,  thymus-derived  lymphocytes;  TNP,  trinitro- 
pheny]. 
426  THE  JOURNAL  OF  EXPERIMENTAL MEDICINE-VOLUME  136,  1972 J. M. DAVIE, W. E. PAUL, D. H. KATZ~  B. BENACERRAF  427 
(d)  DNP-D-GL  is  either  nonimmunogenic  or  only marginally  immunogenic  in 
guinea pigs, presumably because  a pool of functional T  cells specific for DNP-D-GL 
or for D-GL is lacking ~ (1). If functional T cells specific for the tolerogen are lacking,  a 
T  cell locus for tolerance would be excluded. 
(e)  Tolerant animals immunized to DNP-guinea pig albumin (DNP-GPA) have no 
deficit  in delayed hypersensitivity and their lymphocytes transform normally in re- 
sponse to DNP-GPA in culture.  3 
This system of hapten-specific tolerance offers a model to test the hypothesis that 
the induction of tolerance, just as the activation of cells, depends upon the interaction 
of antigen and antibody-like surface receptors. In such a situation, a regimen leading 
to partial tolerance in the pool of precursors of antibody-forming cells should preferen- 
tially eliminate the precursor cells bearing high affinity receptors. Thus, a subsequent 
immune response should be characterized by the production of diminished  amounts of 
antibody and the antibody which is produced should be of low affinity. 
A previous study of the affinity of antibody produced by partially tolerant animals 
has revealed that such antibody is, indeed,  of lower affinity than that produced by 
control immunized animals (8). In this study, however, tolerance was induced by the 
hapten-protein conjugate subsequently used for immunization and thus tolerance may 
have been induced  in both the helper and precursor cell pools. Indeed, in view of the 
demonstration, in mice, that thymus cells are rendered tolerant by lower concentra- 
tions of antigen and appear to remain tolerant for longer periods of time than bone 
marrow cells (9), it seems likely that helper cell (T cell) tolerance existed in the previ- 
ously investigated model. As helper cells play an important role in the activation of 
specific B  cells (5, 6,  10-12a)  and, moreover, may indirectly affect the affinity of the 
antibody produced (13), these previous studies cannot be interpreted unequivocally. 
In the  present studies,  strain  13  guinea pigs were injected  with 0.3  or 3.0 
mg  of  DNP-D-GL,  in  divided  doses,  and  immunized  with  DNP-GPA  2  wk 
or 2 months later. The number of plaque-forming cells (PFC)  in  the draining 
lymph  nodes  and  the  serum  antibody  levels were  measured  10-11,  18,  and 
30-33  days  after DNP-GPA immunization.  In addition,  the  avidity of anti- 
body secreted by PFC was measured by a  hapten-inhibition  technique which 
allows the enumeration of PFC producing antibody of any given avidity (14). 
The affinity of the serum antibody produced was determined by a Farr assay. 
Although the diminution in total antibody response was only modest, especially 
2  months  after  tolerance  induction,  a  very marked  depression  both  in  PFC 
secreting  high  affinity  anti-DNP  antibody  and  in  high  affinity  serum  anti- 
DNP  antibody was noted.  This result indicates  a  preferential  tolerization  of 
precursors bearing high affinity receptors. 
Materials and Methods 
Hapten-Carrier Conjugates.--A copolymer of D-glutamic acid and  9-1ysine (D-GL) was 
obtained from New England Nuclear Corp., Boston, YIass. Guinea pig albumin (GPA) was 
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prepared  from strain  13  guinea pig serum  by  the method  of  Schwert  (15).  Dinitrophenyl 
conjugates of  these materials, DNP53-D-GL  and DNP2~-GPA, were prepared as  previously 
described (1, 16).  Subscripts refer to the number of moles of hapten per mole of carrier. 
Animals,  Tolerance Induction, and I~nmunizatlon.--Adult  strain 13  guinea pigs were ob- 
tained from the Division of Research Services of the National Institutes of Health. I-Iapten- 
specific tolerance was induced by the intraperitoneal injection of either 1.0 mg or 0.1 mg of 
DNPsa-D-GL in saline on 3 successive days (1).  2 wk or 2 months after tolerance induction, 
tolerant animals and untreated animals were immunized by injection, into the footpads,  of 
50/zg of DNP 2.~-GPA emulsified in 0.4 ml of complete Freund's adjuvant (Difco Laboratories, 
Inc.,  Detroit,  Mich.).  On days  10-11,  18,  and 30-33  after immunization, animals were ex- 
sanguinated and draining lymph nodes were removed. Single cell suspensions were prepared 
by  teasing  the  lymph  nodes  in  minimal  essential  medium  (Grand  Islaud  Biological  Co., 
Rockville, Md.)  supplemented with  10% fetal bovine serum  (Industrial Biological Labora- 
tories,  Rockville,  Md.).  Tissue fragments were  allowed  to  settle;  cells which  remained  in 
suspension were washed three times in fresh medium. 
Detection of Anti-DNP Antibody-Secreting Cells and Determination of the Avidity for Hapten 
of the Secreted Antibocly.--Anti-DNP  antibody-secreting cells were detected by a modification 
of the localized hemolysis-in-gel technique, using trinitrophenyl (TNP)-coated sheep erythro- 
cytes (17) ; rabbit polyvalent anti-guinea pig immunoglobulin antiserum was used for facilita- 
tion of hemolysis. Only facilitated plaques were measured. 
The avidity for hapten of the antibody secreted by the plaque-forming cells  (PFC)  was 
determined by a hapten-inhibition method  (14).  E-DNP-L-lysine incorporated into the agar 
can compete with TNP-erythrocytes for anti-DNrP antibody and thereby inhibit the formation 
of plaques.  Plaques inhibitable by low  concentrations of free hapten represent high avidity 
antibody formers; plaques requiring high concentrations of hapten for inhibition represent low 
avidity antibody-forming cells. This is based upon the fact that high affÉnity antibodies may 
be saturated by low concentrations of hapten and thus prevented from binding to and lysing 
the TNP-erythrocytes. Low affinity antibodies, on the other hand, require high ligand con- 
centrations for saturation and thus PFC secreting low affinity antibody are inhibited by high, 
but not low,  concentrations of e-DNP-L-lysine incorporated in the agar. By utilizing a  series 
of ligand concentrations, increasing at tenfold steps, the number of PFC secreting antibody of 
any given avidity can be enumerated. Thus, the PFC secreting the highest avidity antibody 
are those inhibited by 10  -7 M ~-DNP-L-lysine. The number of these ceils is determined by 
subtracting the number of  PFC  in the presence of  10  -7 hapten from the number detected 
with no inhibitor present. The PFC secreting antibody of the next highest avidity range are 
those inhibited by 10  -a M e-DNP-L-lysine but not by 10  -7 M ~-DNP-L-lysine. In this case the 
number of PFC  detected in the presence of  10  -6 M hapten is subtracted from the number 
detected in the presence of 10  -7 ~ hapteu. We routinely evaluate PFC in five avidity ranges; 
the lowest are those which are not inhibited by 10  -4 M ~-DNP-L-lysine and the highest are 
those inhibited by 10  -7 -~ hapten. A detailed analysis of this method and its relation to the 
affinity of serum anti-DNP antibody has been published (14). 
Binding Capacity and A~nity of Serum Anti-DNP Anlibody for  ~-DNP-L-Lysin.e.--The 
affinity of serum anti-DNP antibody for ~-DNP-L-lysine was evaluated by the comparison of 
antigen-binding capacity in a  Farr assay (18)  at a standard concentration of bound and free 
ligand with that at several other concentrations of bound and free ligand, e-DNP-L-lysine-aH 
(14-25  Ci/mM), prepared as previously described (12,  19),  at a final concentration of  either 
0.5 X  10  -a, 0.5 N  10  -7, or 0.5  X  10  -8 M, was mixed with antiserum or antiserum diluted in 
10% normal guinea pig serum. After 30 rain, an equal volume of saturated ammonium sulfate 
was added; 30 rain later the suspension was centrifuged at 2500 rpm at 4°C, and a measured 
aliquot of supernatant added to 6 ml of Aquasol (New England Nuclear Corp.). Radioactivity 
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and the antigen-binding capacity then calculated according to the relation: 
Antigen-binding capacity =  (concentration of bound ligand  X  1/dilution  of 
antiserum required to field such binding). 
Affinity was determined by the following equatiou: 4 
K  = 
R. (B/F)~.B~  --  (B/F)~.B~ 
(l-R) (B,) (B~) 
where, K is the association constant,  R the ratio  of antigen-binding capacity at any experi- 
mental concentration of bound and free ligand to antigen-binding capacity at index condition 
(0.333 X  10  -6 ~ free ligand; 0.167 X  10  -~ ~ bound ligand);  (B/F)I is the ratio of bound to 
free ligand at index condition (0.5); (B/F)x is the ratio of bound to free ligand at test condi- 
tion; Bi is bound ligand concentration at index condition (0.167 X  10  -6 M); and Bx is bound 
ligand concentration at test condition. Antibody populations are evaluated by plotting  log R 
against log K. For homogeneous antibodies, log K is independent of log R but for thermody- 
namically heterogeneous populations log K rises as log R decreases. 
RESULTS 
Pretreatment  of  guinea  pigs  with  DNP-D-GL  diminishes  the  subsequent 
response  of  these  animals  to  DNP-proteins.  Guinea  pigs  immunized  with 
DNP-GPA  2  wk  after  treatment  with  a  total  of 3.0  mg of DNP-D-GL  had 
fewer indirect PFC in their draining lymph nodes and their serum had a lower 
DNP-lysine  binding  capacity  than  nonpretreated  controls.  In  the  current 
experiments  in  which  50  #g  of  DNP-GPA  emulsified  in  complete  Freund's 
adjuvant was used as immunogen, the quantitative  depression of the response 
was  only  modest.  Thus,  10--ll  days  after  immunization,  the  animals  pre- 
treated  with  3.0  mg  of  tolerogen  had  approximately  30%  as  many  PFC  as 
control animals and their serum DNP-lysine binding capacity, when tested  at 
high  (0.5  X  10  -6 M)  ligand  concentration,  was approximately 50%  of that  of 
control  animals  (Table  I).  Although  affinity  as  well  as  concentration  is  im- 
portant  in antigen-binding capacity, the contribution  of affinity is diminished 
at  higher  ligand  concentrations  and  the  values  obtained  with  0.5  X  10-"~ 
e-DNP-L-lysine  more  closely  reflect  antibody  concentrations  than  do  values 
obtained  with  lower  ligand  concentrations.  Guinea  pigs  pretreated  with  0.3 
mg  of  DNP-D-GL  were  intermediate  between  the  control  and  the  3.0  mg 
group in both numbers of PFC and their serum DNP-lysine binding capacity. 
With increasing time after immunization, the degree of depression in the group 
pretreated  with  3,0 mg of DNP-D-GL increased  so that 30-33 days after im- 
munization  these  animals had  10.8%  as many PFC  as  the  control group and 
their serum DNP-lysine binding capacity was 15.0 %  of control. 
If challenge is delayed until  2 months after pretreatment  with  DNP-D-GL, 
little  depression  in  total  PFC  in  draining  lymph  nodes  is  seen  although  the 
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serum DNP-lysine binding  capacity is  still  depressed in  both  groups  of tol- 
erized guinea pigs. 
The avidity of antibody secreted by individual PFC was measured by the 
~-DNP-L-lysine inhibition technique described in Materials and Methods. The 
data is reported as the number of PFC per l0  ~ cells which are inhibited at a 
given ligand concentration but not at a tenfold lower concentration. The highest 
TABLE  I 
Degree  of  Tolerance  in  Guinea  Pigs  Pretreatecl  with  DNP-D-GL 
Interval  Time  Serum  e-DNP-L-lysine  binding 
between  after  capacity* 
tolerance  im-  Pretreatment  Indirect  PFC 
induction  muniza-  0.5  X  10  .6  M  0.5  )<  10  -s 
and  im-  tion  Ligand  Ligand 
munization 
2 wk 
2  months 
days  per 10  s 
10-11  0  642 4- 
0.3 mg DNP-D-GL  452  4- 
3.0 mg DNP-D-GL  201  4- 
18  0  139 4- 
0.3 mg DNP-D-GL  101  4- 
3.0 mg DNP-D-GL  37  4- 
30-31  0  253  4- 
0.3 mg DNP-D-GL  116  4- 
3.0 mg DNP-D-GL  27  4- 
18  0 
0.3 mg DNP-D-GL 
3.0 mg DNP-D  GL 
32-33  0 
0.3 mg DNP-D-GL 
3.0 mg DNP-D-GL 
%4  %4  IO-G M  %o/  cells  Control+,  10 6 M  Control~  Control~; 
133§  --  8.0§  --  0.49~  -- 
94  70.3  5.2  65.0  0.19  38.8 
28  31.3  4.1  51.3  0.19  38.8 
50  --  21.7  --  3.2  -- 
4  73.0  10.8  49.8  0.68  21.3 
5  26.4  5.2  24.0  0.25  7.8 
20  --  28.0  --  7.6  -- 
25  45.8  20.3  72.5  3.9  51.3 
3  10.8  4.2  15.0  0.20  2.6 
8401i  35.0¶  --  4.84  -- 
325  10.4  29.7  0.76  15.7 
530  7.4  21.1  0.23  4.8 
61; 170  38.8  --  18.5  -- 
78  8.9  22.9  1.7  9.2 
70; 146  8.3  21.4  0.65  3.5 
* Serum DNP-lysine binding capacity determined utilizing 0.5 X  10  4  ~  or 0.5 X  10  .8 N ligand concentrations. 
:~ Value for cells  or serum from pretreated  animals/value  for cells or serum from control animals  X  100. 
§ Indirect  PFC  are presented  as arithmetic  mean 4- standard  error; antlgen-blndlng  capacity is determined 
on pool of serum from the same animals, 
][ Yalues for individual animal~ 
¶  Arithmetic mean of individual values from two  or three animals in each group. 
avidity PFC are those inhibited by 10-TM e-DNP-z-tysine; the lowest avidity 
PFC are those not inhibited by 10-4~ e-DNP-L-lysine. 
In those guinea pigs immunized 2 wk after tolerance induction, there was a 
striking  depression  in  the  number  of  PFC  secreting  high  avidity  antibody 
(Fig.  1).  At 10-11 days after immunization, animals tolerized with 3.0 mg of 
DNP-D-GL had only slightly fewer low avidity PFC  than did either the 0.3 
mg tolerant group or the control group. However, the 3.0 mg pretreated group 
had no PFC in the two highest avidity sets although the control animals had 
large  numbers  of PFC  in  both  ranges.  The  animals  pretreated with  0.3  mg 
were suppressed  only in  the PFC  of the highest  avidity set and,  thus,  were 
intermediate between the control and the 3.0 mg tolerant group. 18 days after J. M.  DAVIE, W. E. PAUL, D. tI. KATZ~ B. BENACERRA1  e  431 
immunization,  the  tolerized  groups  still  had  no  PFC  in  the  highest  avidity 
range.  When  tested  30-33  days after priming,  high  avidity PFC  (inhibitable 
by 10  -7 M e-DNP-L-lysine) were present in the 3.0 mg tolerized group. However, 
the frequency of these  cells was considerably less than  that found for the 0.3 
mg tolerized group; in turn, both tolerant groups had considerably fewer high 
affinity PFC  than did the control animals.  In each group, evidence of affinity 
o_ 
lO~  I  Doys I0-II 
io  ~ 
IO 
Days 30-51  Day 18 
Control 
O.Smg  DNP-D-GL 
o---o  30mg  DNP-D-GL 
zlo.4  io.41~  ~-51~6  io-~7 _,1o-7 ~j~4  i~5 i~o  • io-~o-7  ~i~7 ~to-4  io-_4~5  jo-_~  io-.~7  ,_io-7 
PFC  AVIDITY SUBGROUPS  (DNP-LYSINE, M) 
FZG.  1.  Distribution  of PFC  among  avidity groups  in animals  immunized  2 wk  after 
tolerance induction. The ordinate represents the number of PFC per 106 cells in each avidity 
group. The abscissa represents the various avidity groups. Each point is the arithmetic mean 
obtained from the study of cells from three animals. The brackets represent the range encom- 
passed by 4-1 standard error. The group _< 10  -7 is the highest avidity group and represents 
those PFC inhibitable  by 10  -7 ~  e-DNP-lysine. The group  10-6-10  -7 is the next highest 
avidity group and represents  those PFC inhibitable  by 10  -6 ~  e-DNP-L-lysine but not by 
10  -7 M e-DNP-L-lysine. Each successively lower avidity group is indicated in a similar way. 
"'maturation"  of the population  of antibody-secreting cells was noted in  that 
the  frequency of low  and  medium  avidity  PFC  diminished  with  time,  while 
that of high  avidity PFC changed relatively little  in  the control animals  and 
rose in the tolerant animals. 
Analysis of the binding characteristics  of the serum antibody of this  group 
of  animals  also  demonstrated  a  marked  diminution  in  the  affinity  of  anti- 
DNP antibody in the tolerized groups (Fig. 2). As was the case with the PFC, 
the  3.0  mg  tolerant  group  had  antibody  of  the  lowest  affinity,  the  0.3  mg 
tolerant  group had antibody of intermediate  affinity,  and  the control animals 
had  the  highest  affinity antibody.  In one respect,  the  antibody data  differed 
from the PFC data. That is,  the PFC data revealed the most striking avidity 432  ttAPTEN-SPECIFIC  TOLERANCE 
differences  between  tolerized  and  control  groups  at  the  earliest  time  point 
(10-11  days),  whereas  the  difference  in  serum  antibody  affinity  seemed  to 
increase  with  time.  One  possible  explanation  for  this  apparent  discrepancy 
is that we have placed  an arbitrary upper limit on the avidity of the PFC we 
have enumerated. It is possible that had we utilized  10  -s M and 10  -9 M e-DNP- 
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FIG. 2.  Affinity of serum anti-DNP antibody from animals immunized 2 wk after tolerance 
induction. Fach determination was performed on a pool of serum from two or three animals. 
For thcrmod3mamically heterogeneous antibody preparations, log K rises as log R diminishes. 
A comparison of log K for an), given value of log R allows a comparison of the affinity of two 
antibody preparations  to be made. 
z-tysine for inhibition,  the  PFC  data would have more closely resembled  the 
antibody data. 
The data obtained from the stud)- of animals 2 wk after tolerance induction 
suggests  a  marked  degree of tolerance  in the pool of precursor cells with high 
affinity receptors  and little  or no tolerance among precursors with  low affinity 
receptors. In order to obtain information on the stability of this tolerant state, 
we immunized guinea pigs 3 months after tolerance induction.  10-11 days after 
immunization, animals which had been rendered tolerant with 3.0 mg of DNP- 
D-GL  had  no  PFC  secreting  antibodv  of  the  highest  affinity  (inhibitable  by 
10-~M  e-DNP-z-lysine)  but  they  did  possess  essentially  normal  numbers  of 
PFC  inhibitable  by 10-6M E-DNP-L-lysine (Fig. 3).  In this  respect,  then,  the 
tolerance  in  the  2-months group involved onlv the  more avid of the  two sets J. M. DAVIE,  W. E. PAUL, D. H. KATZ, B. BENACERRAF  433 
depressed at 2 wk. Moreover,  the 0.3 mg tolerant group demonstrated an es- 
sentially normal avidity distribution  of PFC whereas, when immunized 2 wk 
after tolerance induction,  this group had a  selective depression in the highest 
avidity PFC.  At  18  and  at 32-33  days after immunization,  the  picture  was 
essentially similar to that at  11  days. That is,  the 3.0 mg tolerant group had 
absent or diminished numbers of high avidity PFC whereas the 0.3 mg tolerant 
103  I  ~  Days  I0-11  Day 18  Days  52-35 
\\  ..~  H  03  mg  DNP-_D-GL 
102  I1 
d  //11/I 
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FIG. 3.  Distribution of PFC among avidity groups in animals immunized 2 months after 
tolerance induction. The ordinate represents the number of PFC per 10 6 cells in each avidity 
group. The abscissa represents the various avidity groups. Each curve represents results from 
an individual animal. The group < 10  -7 is the highest avidity group and represents those PFC 
inhibitable by 10  -7 ~  e-DNP-L-lysine. The group 10-6-10  -7 is the next highest avidity group 
and represents those PFC inhibitable by 10  -6 M e-DNP-L-lysine but not by 10  -7 ~  e-DNP-L- 
lysine. Each successively lower avidity group is indicated in a similar way. 
animals were essentially normal. As before,  the  low avidity PFC  diminished, 
with time, in all groups although some were still detectable in cell populations 
from the tolerant animals at 18 and at 32-33 days after immunization. 
The analysis of serum anti-DNP antibody in the groups immunized 2 months 
after tolerance induction is presented in Fig. 4. The affinity of the serum anti- 
body in the 3.0 mg tolerant group is markedly lower than that of  the control 
animals.  Moreover,  the 0.3  mg tolerant  animals have serum anti-DNP  anti- 
body of intermediate affinity although that was not obvious from the analysis 
of avidity of PFC. 
Thus,  the  animals  immunized  2  months  after  tolerance  induction  had  a 
depressed response even more selective than did the 2-wk animals. This suggests 
that tolerance in  the pool of precursors of intermediate  avidity was lost, per- 434  HAPTEN-SPECLFIC  TOLERANCE 
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Fro. 4.  Affinity of serum anti-DNP  antibody from animals immunized 2 months after 
tolerance induction. Each curve represents results from an individual animal. 
haps through replenishment from bone marrow stem cells, while  the  tolerant 
state was preserved in the pool of precursors of highest avidity. 
DISCUSSION 
In  the  experiments  reported  here,  a  DNP  derivative  of  a  copolymer  of 
9-glutamic and D-lysine induced  a  state of partial  tolerance demonstrable by 
immunizing the treated animals with a DNP derivative of guinea pig albumin. 
In view of the hapten-specific nature of this tolerance and our previous demon- 
stration  that  animals  tolerized  in  this  manner  had  diminished  numbers  of 
lymphocytes capable of binding DNP-GPA-125I  (1),  a  tolerant state exists in 
the population of precursors of anti-DNP  antibody-synthesizing cells. As  the 
copolymer of D-glutamic acid  and D-lysine is either nonimmunogenic or only 
weakly immunogenic in  guinea pigs  (1),  it  seems likely that  thymus-derived 
lymphocytes specific for this compound are lacking or not functional and that 
tolerance induction  occurs because specific B  lymphocytes encounter  antigen 
without  a  simultaneous influence from thymus-derived lymphocytes. In  that 
context,  the induction  of tolerance should be dependent on the concentration 
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cell. The data presented here are in keeping with such a model. Tolerance in- 
duction with DNP-D-GL preferentially depressed the high affinity response to 
DNP-GPA. When guinea pigs were immunized 2 wk after tolerance induction 
with 3.0 mg of DNP-D-GL, the PFC  subsequently generated were markedly 
deficient in the two highest avidity categories whereas animals tolerized with 
0.3 mg of DNP-D-GL showed depression only of the highest avidity PFC which 
we enumerated.  Moreover, if 2  months elapsed  between tolerance induction 
and immunization, the group tolerized with 3.0 mg of DNP-D-GL was depressed 
only in  the highest  avidity PFC  and  the 0.3  mg group was suppressed very 
little. The experiments of Chiller et al. (9) demonstrated that tolerance induced 
by deaggregated human gamma globulin persisted in the T  cell population for 
more than 49 days, whereas bone marrow cell tolerance was lost by 49 days. 
Avidity measurements were not performed in  that study,  and  the rapid loss 
of B  cell tolerance could reflect replenishment with low avidity precursor cells 
or a  selective recovery from a  reversible state of tolerance dependent on the 
preferential loss of tolerogen from low affinity receptor sites. Our demonstra- 
tion that specific tolerance existed for at least 2 months in the highest avidity 
precursor population raises the possibility that in the pool of high affinity B 
cells tolerance may be long lasting.  On the other hand,  the present model of 
tolerance induction utilizes a  nonmetabolizable compound which may persist 
for 2 months or more at levels sufficient to maintain the tolerant state in the 
highest affinity B  cell population or to tolerize newly emerging precursor cells 
with  receptors of high  affinity for DNP. 
Let us now turn to certain possible objections to our model for the induction 
of tolerance by DNP-D-GL and of recovery from this  tolerant state.  Firstly, 
we have not formally proved that T lymphocytes specific for 9-GL or for DNP- 
B-GL are not present in guinea pigs. Indeed, formal proof on this issue is prob- 
ably not  available  in  any  current system as  it  requires  enumeration  of  the 
specific T  cell without stimulation  of these  cells.  For T  lymphocytes this  is 
not yet routinely feasible. We have shown that DNP-D-GL does not induce a 
sustained  anti-DNP  antibody response or a  state of cellular hypersensitivity 
nor is 9-GL capable of acting as a helper or carrier molecule (1). Nonetheless, 
we cannot exclude the possibility that a class of suppressor T  cells specific for 
DNP-D-GL are activated and that such cells play a role in the suppression of 
B  cells.  Definitive experiments to test this possibility are underway in mice. 
The second objection which may be offered deals with  the use of avidity 
distribution in PFC and affinity measurements in antibody molecules to evalu- 
ate  the  receptor characteristics  of precursor cells.  It  seems  quite  clear  that 
the binding properties of the receptor on the precursor cell and of the antibody 
secreted by  the  descendent  are  similar  or  identical  (14).  Furthermore,  pre- 
liminary study of the binding of DNP-GPA-125I by lymphoid cells in animals 
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receptors when compared with the situation in control immunized guinea pigs. 
A  similar finding has recently been observed by M611er and  Mgkelg utilizing 
rosette  formation  as  a  measure  of  antigen  binding. ~ However,  population 
changes in  the course of the immune response complicate extrapolation from 
the affinity characteristics of cells in  immunized  animals  to  those  of the  re- 
ceptors on precursors in nonimmunized animals. In particular, it may be argued 
that increasing concentrations of antibody preferentially suppress low affinity 
precursors and that the lower avidity we observe is due completely or in part 
to such an antibody regulatory effect. Although ample evidence exists for the 
capacity of antibody to suppress low affinity precursors (20, 21), the regulatory 
effect of such antibody can hardly be responsible for the selective depression 
exhibited by tolerized animals which we have described in this report. 
Thus,  the prime difference exhibited by tolerized animals is  the  failure of 
high affinity PFC to appear rather than an abnormal retention of low affinity 
PFC.  Moreover, serum anti-])NP  antibody concentrations are only modestly 
depressed at  10--11 day-s after immunization. The combined effects of normal 
loss of low avidity PFC and absent or diminished numbers of high avidity PFC 
causes the degree of tolerance to increase with time after immunization. Finally, 
high avidity PFC are easily detectable at 6 days after immunization in normal 
animals,  before the appearance of detectable serum anti-DNP  antibody (14). 
Antibody regulation can hardly be important in the appearance of these cells. 
Thus, the lack of high avidity PFC 18 day's after immunization in the tolerant 
groups strongly indicates a selective induction of tolerance in precursors bear- 
ing high affinity receptors. 
Our data support the concept that, in the absence of thymus-derived lympho- 
cytes,  the  interaction  of  an  excess  of  antigen  with  precursors  of  antibody- 
secreting  cells  generally leads  to  a  tolerant  state  and  that  the  induction  of 
tolerance depends on the interaction of some requisite number or proportion of 
cell receptors with antigen. Nonetheless, there are conditions, even in the ab- 
sence of T  cells,  in  which  activation of precursors occurs  (22,  23)  but  these 
conditions  may be  very precise particularly in  terms  of  amount  of  antigen 
bound to cell receptors (24). In such a  model, the T  cell would be viewed as 
having a regulatory role and allowing a much wider range of antigen concen- 
trations to be stimulatory for a given B cell than would be true in the absence 
of T  cells. 
SUMMARY 
The induction of tolerance in guinea pigs with a  2,4-dinitrophenyl (DNP) 
derivative of a copolymer of copolymer of D-glutamic acid and D-lysine (o-GL) 
leads  to  a  preferential  depression  of  the  capacity  to  produce  high  affinity 
M611er, E., and O. M~tkel/t. 1972. Antigen binding cells in immune and tolerant  mice. 
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anti-DNP  antibody in  response to immunization with DNP-guinea pig albu- 
min. Thus,  immunization 2 wk after tolerance induction  with 3 mg of DNP- 
D-GL results in  an immune response in which individual plaque-forming cells 
(PFC)  secreting high affinity anti-DNP antibody are absent and in  which the 
affinity of circulating anti-DNP antibody is reduced. A similar, but less marked, 
suppression is seen when 0.3 mg of DNP-D-GL is used for tolerance  induction. 
If  immunization  is  delayed  until  2  months  after  tolerance  induction,  then 
suppression  is  restricted  to  the  highest  avidity PFC  group.  Our  data  is  con- 
sistent with a state of tolerance in the pool of precursors of anti-DNP antibody- 
secreting cells induced  as a  result of their interaction with DNP-D-GL in the 
absence of specific "helper" cells,  which appear to be lacking for  DNP-D-GL. 
In such  a  situation,  the  affinity of receptors on  precursor cells for  tolerogen 
and the concentration of tolerogen appear to be crucial determinants of whether 
an individual cell will become tolerant. 
We thank Mrs. Barbara Johnson for expert technical assistance. 
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